These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 432587)

  • 1. [Dosage dependence of the effect of somatostatin on human splanchnic blood flow].
    Keller U; Sonnenberg GE; Kayasseh L; Gyr K; Perruchoud A
    Schweiz Med Wochenschr; 1979 Apr; 109(16):595-6. PubMed ID: 432587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of somatostatin on splanchnic hemodynamics in patients with cirrhosis of the liver and in normal subjects.
    Sonnenberg GE; Keller U; Perruchoud A; Burckhardt D; Gyr K
    Gastroenterology; 1981 Mar; 80(3):526-32. PubMed ID: 6108898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of bolus injections and continuous infusions of somatostatin and placebo in patients with cirrhosis: a double-blind hemodynamic investigation.
    Cirera I; Feu F; Luca A; García-Pagán JC; Fernández M; Escorsell A; Bosch J; Rodés J
    Hepatology; 1995 Jul; 22(1):106-11. PubMed ID: 7601400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of somatostatin on splanchnic glucose metabolism in postabsorptive and 60-hour fasted humans.
    Wahren J; Efendić S; Luft R; Hagenfeldt L; Björkman O; Felig P
    J Clin Invest; 1977 Feb; 59(2):299-307. PubMed ID: 833277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin infusion inhibits glucose production in burn patients.
    Wolfe RR; Burke JF
    Circ Shock; 1982; 9(5):521-7. PubMed ID: 6129073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prandial regulation of ghrelin secretion in humans: does glucagon contribute to the preprandial increase in circulating ghrelin?
    Soule S; Pemberton C; Hunt P; Cole D; Raudsepp S; Inder W
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):412-7. PubMed ID: 16181233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of somatostatin on splanchnic hemodynamics in liver cirrhosis].
    Merkel C; Gatta A; Zuin R; Finucci GF; Arnaboldi L; Ruol A
    Minerva Med; 1984 Nov; 75(44):2673-8. PubMed ID: 6151151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin.
    Bosch J; Kravetz D; Rodes J
    Gastroenterology; 1981 Mar; 80(3):518-25. PubMed ID: 6108897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating platelet aggregates induced by somatostatin in insulin-dependent diabetic subjects.
    Coppola L; Giugliano D; Tirelli A; Misso L; Sgambato S; D'Onofrio F
    Diabete Metab; 1980 Dec; 6(4):245-9. PubMed ID: 6110570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of glucose on hepatic conversion of aminonitrogen to urea in patients with cirrhosis: relationship to glucagon.
    Hamberg O; Vilstrup H
    Hepatology; 1994 Jan; 19(1):45-54. PubMed ID: 7903954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin.
    Gerich JE; Lorenzi M; Bier DM; Tsalikian E; Schneider V; Karam JH; Forsham PH
    J Clin Invest; 1976 Apr; 57(4):875-84. PubMed ID: 820717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulatory effects of somatostatin in anesthetized man.
    Tydén G; Samnegård H; Thulin L; Muhrbeck O; Efendić S
    Acta Chir Scand; 1979; 145(7):443-46. PubMed ID: 161458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ketone bodies on glucose production and utilization in the miniature pig.
    Müller MJ; Paschen U; Seitz HJ
    J Clin Invest; 1984 Jul; 74(1):249-61. PubMed ID: 6376544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for an important role of glucagon in the regulation of hepatic glucose production in normal man.
    Liljenquist JE; Mueller GL; Cherrington AD; Keller U; Chiasson J-L ; Perry JM; Lacy WW; Rabinowitz D
    J Clin Invest; 1977 Feb; 59(2):369-74. PubMed ID: 833282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of a long-acting somatostatin analogue on splanchnic haemodynamics and metabolism in healthy subjects and patients with liver cirrhosis.
    Wahren J; Eriksson LS
    Scand J Gastroenterol Suppl; 1986; 119():103-8. PubMed ID: 2876492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple subcutaneous injections of somatostatin induce tachyphylaxis of the suppression of plasma insulin, but not glucagon, in the rat.
    Märki F; Bucher UM; Richter JC
    Regul Pept; 1982 Nov; 4(6):333-9. PubMed ID: 6129682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Splanchnic metabolism of alanine in intact man. Effects of somatostatin and somatostatin plus insulin.
    Rabin D; Mueller GL; Lacy WW; Liljenquist JE
    Diabetes; 1979 May; 28(5):486-90. PubMed ID: 437378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of different octreotide dosages on splanchnic hemodynamics and glucagon in healthy volunteers.
    Schiedermaier P; Brensing KA; Göke B; Schätzle T; Sauerbruch T
    Digestion; 1999; 60(2):132-40. PubMed ID: 10095154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further studies on the significance of circulating platelet aggregates induced by somatostatin in man.
    Giugliano D; Coppola L; Misso L; Tirelli A; Passariello N; D'Onofrio F
    Metabolism; 1981 Feb; 30(2):172-5. PubMed ID: 6110160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatostatin plasma levels and biological effects following subcutaneous administration of somatostatin in man.
    Uccioli L; Ghirlanda G; Cotroneo P; Manto A; Solini A; Greco AV
    Acta Endocrinol (Copenh); 1986 Dec; 113(4):465-70. PubMed ID: 2878551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.